Clinical predictors of 3-month isoniazid rifapentine (3HP)-related adverse drug reactions (ADR) during tuberculosis preventive therapy (PAnDoRA-3HP study): an observational study protocol.
Sekaggya-Wiltshire C, Mbabazi I, Nabisere RM, Alinaitwe L, Otaalo B, Aber F, Nampala J, Owori R, Bayigga J, Mayito J, Banturaki G, Laker EAO, Castelnuovo B, Sekadde MP, Pasipanodya J, Dooley KE, Stavia T, Zawedde-Muyanja S.
Sekaggya-Wiltshire C, et al. Among authors: castelnuovo b.
BMJ Open. 2024 Dec 31;14(12):e088389. doi: 10.1136/bmjopen-2024-088389.
BMJ Open. 2024.
PMID: 39740953
Free article.